Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000546624 | SCV000655415 | benign | Periodic fever-infantile enterocolitis-autoinflammatory syndrome; Familial cold autoinflammatory syndrome 4 | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000546624 | SCV000782771 | uncertain significance | Periodic fever-infantile enterocolitis-autoinflammatory syndrome; Familial cold autoinflammatory syndrome 4 | 2018-02-08 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV000546624 | SCV002495868 | uncertain significance | Periodic fever-infantile enterocolitis-autoinflammatory syndrome; Familial cold autoinflammatory syndrome 4 | 2022-02-16 | criteria provided, single submitter | clinical testing | NLRC4 NM_021209.4 exon 6 p.Gly786Val (c.2357G>T): This variant has been reported in the literature in at least 1 individual with Presumed Ocular Histoplasmosis Syndrome (POHS) (Li 2020 32707200). This variant is present in 0.4% (288/68040) of European alleles including 3 homozygotes in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/2-32238296-C-A?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:475252). Evolutionary conservation suggests that this variant may not impact the protein; computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ce |
RCV001706673 | SCV002498548 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | NLRC4: BP4, BS2 |
Genome Diagnostics Laboratory, |
RCV002263805 | SCV002543545 | benign | Autoinflammatory syndrome | 2022-02-23 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV002268166 | SCV002552164 | uncertain significance | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003925704 | SCV004745798 | benign | NLRC4-related disorder | 2019-11-21 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001706673 | SCV001928107 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001706673 | SCV001971398 | likely benign | not provided | no assertion criteria provided | clinical testing |